Ileal mucosa-associated lymphoid tissue lymphoma presenting with small bowel obstruction: a case report by unknown
CASE REPORT Open Access
Ileal mucosa-associated lymphoid tissue
lymphoma presenting with small bowel
obstruction: a case report
Zoe Kinkade1, Olukemi A. Esan1*, Flavia G. Rosado1, Michael Craig2 and Jeffrey A. Vos1
Abstract
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) of the
gastrointestinal tract commonly involves the stomach in the setting of concurrent Helicobacter pylori (H. pylori)
infection. Primary ileal MALT lymphoma is rare, and has not been associated with a specific infectious disease.
We report a case of a 58-year-old man who presented to the emergency department with constipation and abdominal
distension, and signs of an obstructing mass on computed tomography scan. A small bowel resection was performed
which revealed an 8 cm saccular dilatation with thickened bowel wall and subjacent thickened tan-yellow tissue
extending into the mesentery. Histologically, there was a diffuse lymphoid infiltrate consisting of small atypical cells
with monocytoid features. These cells were CD20-positive B-lymphocytes that co-expressed BCL-2 and were negative
for CD5, CD10, CD43, and cyclin D1 on immunohistochemical studies. Kappa-restricted plasma cells were also identified
by in situ hybridization. The overall proliferation index was low with Ki-67 immunoreactivity in approximately 10 % of
cells. No areas suspicious for large cell or high grade transformation were identified. The pathologic findings were
diagnostic of an extranodal marginal zone lymphoma involving the ileum, with early involvement of mesenteric lymph
nodes. Small hypermetabolic right mesenteric and bilateral hilar lymph nodes were identified by imaging. The bone
marrow biopsy showed no evidence of involvement by lymphoma. The patient was clinically considered advanced
stage and opted for therapy with rituximab infusions. After six months of therapy, follow-up radiologic studies
demonstrated significant decrease in size of the mesenteric lymph nodes.
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Background
The gastrointestinal tract is involved by 30-40 % of all
extranodal non-Hodgkin lymphomas [1]. The majority
(60-75 %) of the extranodal lymphomas within the
gastrointestinal tract involve the stomach and are associ-
ated with Helicobacter pylori (H.pylori) infection [1–3].
Involvement of other sites of the gastrointestinal tract by
extranodal lymphomas has been reported including
colon, jejunum, ileum and rectum [1, 2]. When lymph-
omas arise in the small bowel, they are most often diffuse
large B-cell lymphomas; however, MALT lymphomas rep-
resent one third of the small bowel lymphomas [4, 5]. A
variant of extranodal marginal zone lymphomas has been
described in the duodenum known as immunoprolifera-
tive small intestine disease (IPSID) with a clinical mani-
festation of abdominal pain, diarrhea and malabsorption,
which is prevalent in the middle East and Africa [6, 7].
Other extranodal lymphomas described in the small bowel
are Burkitt lymphoma, mantle cell lymphoma, follicular
lymphoma and T-cell lymphomas [4].
Extranodal marginal zone lymphoma typically arises in
areas where mucosa-associated lymphoid tissue (MALT)
has been acquired, but not necessarily where it is found
under normal circumstances, such as the Peyer’s patches.
In these acquired areas, lymphoma is believed to arise as a
result of some chronic antigenic or inflammatory stimulus
such as H. pylori gastritis or autoimmune process such as
celiac disease, Sjogren syndrome, or Hashimoto’s thyroid-
itis [6]. Gastric cases associated with Helicobacter pylori
* Correspondence: oesan@hsc.wvu.edu
1Department of Pathology, West Virginia University, PO Box 9203,
Morgantown, WV 26506, USA
Full list of author information is available at the end of the article
© 2015 Kinkade et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kinkade et al. Diagnostic Pathology  (2015) 10:105 
DOI 10.1186/s13000-015-0353-6
infection may regress with antibiotic therapy [6, 8]. How-
ever, in other regions of the gastrointestinal tract antibiotic
therapy has been found to be less effective [9]. Risk factors
for small bowel lymphomas has been found to include im-
munodeficiency, inflammatory bowel disease and malab-
sorption syndromes [9]. In other sites, associations with
other infectious agents, such as Campylobacter jejuni in
the proximal small bowel, Borrelia burgdorferi in the skin,
and Chlamydia psittaci in ocular adnexa, have also been
described [6]. MALT lymphoma is an indolent lymphoma
with an overall 5-year survival rate of 81 % [10]. It is a
low-grade malignancy and is usually localized at the time
of diagnosis. As such, patients often present at an early
stage, even though they may have experienced and over-
looked non-specific symptoms prior to diagnosis [11].
MALT lymphomas are thought to arise from the post-
germinal center B-cells, normally found in the marginal
zone of lymphoid follicles [12]. These malignant cells ex-
pand this zone and spill into the interfollicular areas,
expanding beyond the dendritic meshwork of the follicle.
In areas containing epithelial structures, the characteris-
tic “lymphoepithelial lesions” are commonly present and
Fig. 1 a Gross specimen, distal ileum with saccular dilatation. b Gross specimen, ileum, incised to show hemorrhagic mucosa within
saccular dilatation
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characterized by eosinophilic degeneration of epithelial
cells with influx of malignant lymphocytes [6]. The B-
cells are generally small, with slightly irregular nuclei
and moderate to abundant clear cytoplasm, accounting
for the prototypical “monocytoid” appearance associated
with this type of lymphoma. Plasmacytic differentiation
may occur in a third of gastric MALT lymphomas [6].
By immunohistochemistry, the neoplastic cells express
the pan-B-cell markers CD19, 20, 22, and 79a. Plasma
cell differentiation can be demonstrated by CD 138 ex-
pression and concurrent light chain restriction. The den-
dritic cell meshwork are highlighted by CD21 and CD35,
which may be helpful to demonstrate when the diagnosis
of lymphoplasmacytic lymphoma is entertained, since, in
such cases, a residual dendritic cell meshwork is not typ-
ically seen. CD5, CD10, and cyclin D1 are classically
negative, aiding in differentiation of MALT from other
low-grade B-cell lymphomas such as chronic lympho-
cytic lymphoma (typically CD5 positive), mantle cell
lymphoma (typically CD5 positive), and follicular lymph-
oma (typically CD10 positive). Rarely, the malignant B-
cells in marginal zone lymphoma may express CD5,
posing a diagnostic challenge [6]. CD43 is positive in
about half of the cases, and can help to differentiate
a malignant proliferation (CD43 positive B-cells) from
reactive MALT tissue [6]. Despite the above-described
Fig. 2 a Ileal wall with transmural nodular lymphocytic infiltrate. H&E. 20x. b Lymphoplasmacytic infiltrate with monocytoid features. H&E. 200x
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phenotypic features, there are no markers specific for
marginal zone lymphoma. Due to this non-descript
phenotype, a light-chain restricted B-cell population,
negative for both CD5 and CD10, must be evaluated
in conjunction with the morphologic findings to con-
firm the diagnosis.
The most common associated chromosomal abnormal-
ity in MALT lymphoma (particularly of gastric and pul-
monary origin) is the t(11:18) (q21;q21) resulting in fusion
of the API2 and MALT1 genes, occurring in approxi-
mately 50 % of cases [6, 12]. Cases that are positive for
t(11:18) (q21;q21) tend to not regress following therapy di-
rected at eradicating H. pylori. Other translocations asso-
ciated with extranodal marginal zone lymphoma include
t(1;14) (p22;q32), t(3:14) (p14;q32), and t(14;18) (q32;q21)
[6]. Other non-specific trisomies have been reported in
extranodal marginal zone lymphomas [6].
While extranodal marginal zone lymphoma of mucosa-
associated lymphoma tissue (i.e., MALT lymphoma) is one
of the more common primary gastrointestinal lymphomas,
a review of the literature shows very few reported cases of
primary MALT lymphoma involving the ileum, occurring
predominantly in Asian patients [1, 4, 10]. The authors
herein present a case of primary ileal MALT lymphoma
presenting with bowel obstruction in a Caucasian adult.
Case presentation
A 58-year-old Caucasian male presented to the emer-
gency department with complaints of constipation and
abdominal distension. He had experienced nausea and
decreased bowel movements for a week, which were not
alleviated by stool softeners or enemas. There was no
history of diarrhea, fever, chills, weight changes, night
sweats, hematochezia, or melena. A colonoscopy 4 years
prior had only revealed a small benign polyp. The pa-
tient otherwise had no significant past medical history
and was not taking any medications. No history of ab-
dominal surgeries or significant family history of cancer
was elicited. He denied the use of alcohol or smoking,
but admitted to using smokeless tobacco. Vital signs and
physical exam were essentially unremarkable. The abdo-
men was not visibly distended and normal bowel sounds
were present. No hepatosplenomegaly or lymphadenop-
athy was appreciated. Laboratory results showed normal
complete blood count, coagulation parameters, electro-
lytes, liver function tests, pancreatic enzymes, and kidney
function. Alpha fetoprotein (AFP) and carcinoembryonic
antigen (CEA) were within normal limits. An abdominal
computed tomography scan (CT scan) was concerning for
a neoplasm causing small bowel obstruction, showing mid
to distal small bowel dilatation with abnormal wall thick-
ening and significant retained debris. The patient under-
went a laparotomy and resection of a distal segment of
ileum was performed.
On gross examination, a 39 cm portion of distal ileum
was received and the central portion contained an 8 cm
length saccular dilatation that had a hemorrhagic and
nodular mucosa (Fig. 1a and b). The bowel wall mea-
sured up to 0.9 cm in thickness and demonstrated
underlying, ill-defined pale yellow tissue extending into
Fig. 3 a Lymphocytic infiltrate consists predominantly of CD20 positive B-cells. CD20 immunohistochemical stain. 200x. b B-cells are negative for
CD5 which highlights scattered T-cells. CD5 immunohistochemical stain. 200x. c B-cells are predominantly negative for CD10 which highlights
few residual germinal center B-cells. CD10 immunohistochemical stain. 200x
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the mesentery. On microscopic examination, an exten-
sive transmural atypical nodular and diffuse lymphoid
infiltrate was present and consisted predominantly of
small B-lymphocytes, few plasma cells and focal areas of
monocytoid B-cells (Fig. 2a and b). This lymphoid infil-
trate extended into the subserosal adipose tissue. The
majority of nodules did not contain germinal centers;
however, few scattered small germinal centers were
noted. Overlying the atypical lymphoid infiltrate, villous
structures of the intestinal epithelium was flattened and
focally denuded with sparse epithelial crypts and few
lymphoepithelial lesions. No foci of necrosis were identi-
fied. No areas suspicious for large cell or high grade
transformation were identified. The uninvolved mucosa
was unremarkable with normal villi and crypt architec-
ture. The atypical lymphoid cells were positive for CD20
(Fig. 3a) and BCL-2, while negative for CD5 (Fig. 3b),
CD10 (Fig. 3c), CD43, and cyclin D1 by immunohisto-
chemistry. The CD138 positive plasma cells (Fig. 4a)
were most numerous and clustered beneath the mucosal
surface and were kappa-restricted by light chain in situ
hybridization studies (Fig. 4b and c). The residual dendritic
meshwork within lymphoid nodules was identified by
CD23 staining (Fig. 5). The proliferation rate of the lesion
was low, with a Ki-67 percentage of approximately 10 %
(Fig. 6). The overall morphologic and immunophenotypic
Fig. 5 Residual dendritic meshwork identified within lymphocytic
infiltrate. CD23 immunohistochemical stain. 100x
Fig. 6 Lymphocytic infiltrate with low proliferation index. Ki-67
immunohistochemical stain. 200x
Fig. 4 a Clusters of plasma cells located near the mucosal surface. CD138 immunohistochemical stain. 200x. b Plasma cells with predominantly
kappa light chain. Kappa in situ hybridization. 200x. c Rare plasma cell with lambda light chain. Lambda in situ hybridization. 200x
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features are consistent with a diagnosis of marginal zone
lymphoma. Few prominent lymph nodes were identified in
the mesentery (measuring up to 1.5 cm in greatest diam-
eter). Microscopic examination showed partial effacement
of these mesenteric lymph nodes with germinal center infil-
tration by BCL-2 positive B-cells, consistent with partial
nodal involvement by marginal zone lymphoma.
The large ileal mass in the setting of small mesenteric
and hilar lymph nodes was clinically consistent with a
diagnosis of extranodal marginal zone lymphoma arising
from the ileum. A complete staging evaluation including
PET and CT imaging studies revealed additional small hy-
permetabolic mesenteric and bilateral hilar lymph nodes.
No other lesions were noted in the stomach, thyroid, liver,
pancreas or other organs. A staging bone marrow biopsy
was negative for involvement by lymphoma, by morpho-
logic and flow cytometric analysis. The patient was clinic-
ally staged as 3E (lymphadenopathy above and below the
diaphragm). Treatment was initiated with single agent ri-
tuximab (monoclonal antibody against CD20) every other
month, and is planned to continue for 2 years. After six
months of treatment, the patient was asymptomatic and
radiologic studies demonstrated significant decrease in
size of the mesenteric lymph nodes.
Discussion
Small bowel obstruction in industrialized countries is usu-
ally due to adhesions, which account for approximately
70 % of cases [13]. Other causes of small bowel obstruc-
tion are malignancies, inflammatory bowel disease and
hernias. Pre-op detection of small bowel malignancies is
improved with the introduction of new sophisticated
endoscopic techniques (e.g. capsule endoscopy). However,
due to non-specific clinical presentations, diagnosis in
many patients is delayed [4].
Diffuse large B-cell lymphoma is the most common pri-
mary gastrointestinal tract lymphoma, with the small
bowel as the site of origin 15–30 % of the time [5]. MALT
lymphoma of the small bowel is rare. The differential diag-
nosis of MALT lymphoma in this site includes immuno-
proliferative small intestinal disease (IPSID), an alpha
heavy chain disease that usually occurs in the proximal
small intestine (duodenum), and shows prominent plasma-
cytic differentiation without demonstrable light chain
expression [6, 7]. IPSID has been associated with Campylo-
bacter jejuni infection [7] rather than with Helicobacter pyl-
ori infections seen in gastric MALT lymphomas. This is an
unusual case in which extranodal marginal zone lymphoma
presented as ileal obstruction, in a patient with no known
history of a chronic inflammatory or autoimmune disease.
Conclusions
In conclusion, this case represents a rare case of extranodal
marginal zone lymphoma involving the ileum presenting
as small bowel obstruction. Further studies are required to
understand the etiology of ileal MALT lymphomas, with
possible identification of causative agents and better under-
standing of pathogenesis of this malignancy. Eradication of
treatable infectious organisms may help in preventing the
occurrence of ileal MALT lymphomas in the future. Ap-
propriate identification of these cases is important for early
intervention, and proper management that includes tar-
geted agents and chemotherapy, with possible avoidance of
surgical procedures.
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